Roberto Coppari is Professor at the Faculty of Medicine of the University of Geneva in Switzerland where he also directs the Faculty Diabetes Center (since 2015) and the Metabolic Core facility (since 2017). Dr. Coppari has been using genetically-engineered mice to dissect the neuronal and peripheral mechanisms underlying glucose, lipid, and energy balance in health and disease (e.g. diabetes). His work also focused on understanding how insulin-deficiency-induced lethality could be overcome without the need of injected insulin. Dr. Coppari is also interested in understanding how metabolic pressure (e.g. hyper-caloric feeding) affects cancer cell behavior and stem-like features. His research unraveled new putative targets for treatment of metabolic and cancerous diseases (e.g. FKBP10, PTPRg) and pathways permitting life without insulin (e.g. leptin and its downstream effectors). Dr. Coppari received a PhD in Neuroscience and performed his pre-graduate and post-graduate training at Harvard Medical School in Boston, MA, USA. His independent career started in 2007 when he was appointed Assistant Professor at University of Texas Southwestern Medical School in Dallas, TX, USA. His research was and has been funded by several agencies as for example the European Research Council (e.g. ERC consolidator grant), the USA National of Institutes of Health (e.g. RO1 grants), the Swiss Cancer League, and the Swiss National Science Foundation.